| Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma T Hara, R Chanoch-Myers, ND Mathewson, C Myskiw, L Atta, L Bussema, ... Cancer cell 39 (6), 779-792. e11, 2021 | 409 | 2021 |
| Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis ND Mathewson, O Ashenberg, I Tirosh, S Gritsch, EM Perez, S Marx, ... Cell 184 (5), 1281-1298. e26, 2021 | 320 | 2021 |
| Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours A Gavish, M Tyler, AC Greenwald, R Hoefflin, D Simkin, ... Nature 618 (7965), 598-606, 2023 | 213 | 2023 |
| Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma A Spitzer, S Gritsch, M Nomura, A Jucht, J Fortin, R Raviram, ... Cancer Cell 42 (5), 904-914. e9, 2024 | 24 | 2024 |
| Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis R Chanoch-Myers, A Wider, ML Suva, I Tirosh Genome medicine 14 (1), 106, 2022 | 20 | 2022 |
| Glioblastoma Cortical Organoids Recapitulate Cell-State Heterogeneity and Intercellular Transfer V Mangena, R Chanoch-Myers, R Sartore, B Paulsen, S Gritsch, ... Cancer Discovery 15 (2), 299-315, 2025 | 5 | 2025 |
